Aligos Therapeutics Newsroom

Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 17% Last Week

Yahoo FinanceDec 21, 2024 21:43

NASDAQ New 52-Week Highs And Lows

Dow JonesDec 14, 2024 05:22

Express News | Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 13, 2024 21:00

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 13, 2024 21:00

Aligos Therapeutics to Present at Investor Conferences in December

GlobeNewswireNov 26, 2024 21:00

Express News | Adage Capital Management, L.p. Reports 7.12% Passive Stake in Aligos Therapeutics as of Sept 30 - SEC Filing

BreakingsNov 12, 2024 23:20

Aligos Therapeutics Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 60%

BenzingaNov 11, 2024 23:23

H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $75

Futu NewsNov 7, 2024 20:33 · Ratings

Aligos Therapeutics Q3 2024 GAAP EPS $(3.07) Misses $(2.15) Estimate, Sales $1.269M Beat $333.333K Estimate

BenzingaNov 7, 2024 07:00

Express News | Aligos Therapeutics Inc Files for Mixed Shelf of up to $400 Mln - SEC Filing

BreakingsNov 7, 2024 06:15

Express News | Aligos Therapeutics Inc - Cash Balance Provides Sufficient Cash to Fund Planned Operations Through End of 2025

BreakingsNov 7, 2024 06:03

Aligos Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 7, 2024 05:28 · Announcements

Aligos Therapeutics | 8-K: Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

SECNov 7, 2024 05:09

Aligos Therapeutics 3Q Loss/Shr $3.07 >ALGS

Dow JonesNov 7, 2024 05:05

Earnings Preview: ALGS to Report Financial Results Post-market on November 06

$Aligos Therapeutics(ALGS.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Aligos Therapeutics(ALGS.US)$ to post revenue of USD333.3

Futu NewsOct 31, 2024 13:45

Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024

GlobeNewswireOct 31, 2024 04:05

Aligos Therapeutics' Promising Clinical Advancements and Buy Rating Driven by Strong Market Potential

TipRanksOct 23, 2024 18:25 · Ratings

Aligos Therapeutics up on FDA Clearance of IND Application for Its Hepatitis B Treatment

Seeking AlphaOct 22, 2024 21:01

Express News | Aligos Therapeutics Inc - Phase 2 Filing for Alg-000184 Planned for Q1 2025

BreakingsOct 22, 2024 20:03

Express News | Aligos Therapeutics Announces U.S. FDA Clearance of Ind Application for Alg-000184

BreakingsOct 22, 2024 20:00